Home4503 • TYO
add
Astellas Pharma Inc
Previous close
¥1,588.00
Day range
¥1,583.00 - ¥1,595.00
Year range
¥1,426.00 - ¥2,270.00
Market cap
2.88T JPY
Avg Volume
7.22M
P/E ratio
167.88
Dividend yield
4.40%
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
(JPY) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 414.60B | 17.04% |
Operating expense | 281.61B | 17.33% |
Net income | -33.28B | 27.85% |
Net profit margin | -8.03 | 38.33% |
Earnings per share | — | — |
EBITDA | 108.40B | 44.60% |
Effective tax rate | 31.61% | — |
Balance Sheet
Total assets
Total liabilities
(JPY) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 364.47B | -8.11% |
Total assets | 3.57T | 45.31% |
Total liabilities | 1.97T | 108.06% |
Total equity | 1.60T | — |
Shares outstanding | 1.79B | — |
Price to book | 1.78 | — |
Return on assets | 4.31% | — |
Return on capital | 6.00% | — |
Cash Flow
Net change in cash
(JPY) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -33.28B | 27.85% |
Cash from operations | 71.98B | -37.73% |
Cash from investing | -22.16B | 2.47% |
Cash from financing | 30.93B | 129.60% |
Net change in cash | 81.71B | 1,742.06% |
Free cash flow | 52.44B | 248.41% |
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
14,754